Aptinyx Inc. Banner Image

Aptinyx Inc.

  • Ticker APTX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Aptinyx Inc. Logo Image
  • 11-50 Employees
  • Based in Evanston, Illinois
Aptinyx Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of proprietary synthetic small molecules for the treatment of brain and nervous system disorders. Aptinyx has a platform for discovery of novel compounds that work through a unique mechanism to modulate—rather than block or over-activate—NMDA receptors and enhance synapticMore plasticity, the foundation of neural cell communication. The company has three product candidates in clinical development in central nervous system indications, including chronic pain, post-traumatic stress disorder, and cognitive impairment associated with Parkinson’s disease. Aptinyx is also advancing additional compounds from its proprietary discovery platform, which continues to generate a rich and diverse pipeline of small-molecule NMDA receptor modulators with the potential to treat an array of neurologic disorders.
4.8 / 5.0 (298)

Aptinyx Inc. reports have an aggregate usefulness score of 4.8 based on 298 reviews.

Aptinyx Inc.

Most Recent Annual Report

Aptinyx Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Aptinyx Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!